Vimarsana
Biggest News Aggregation in the World

Cellecti Pulseagile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellecti Pulseagile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellecti Pulseagile Today - Breaking & Trending Today

Cellectis S A : Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications - Vimarsana News

Cellectis S A : Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications

Published: June 12, 2024

Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications 12 Jun 2024 22:30 CEST ...

Source: marketscreener.com
Related Topics:
France GeneralNorth CarolinaUnited StatesNew YorkAshleyr RobinsonPascalyne WilsonCellecti PulseagilePatricia Sosa NavarroArthur StrilJulien ValtonCellectis The Company Euronext GrowthSecurities Exchange CommissionNature CommunicationsEuronext GrowthVice President Gene TherapyAdult HemoglobinSickle HemoglobinNasdaq Global MarketPrivate Securities Litigation Reform ActAnnual ReportSosa NavarroInterim Chief Financial OfficerLifesci Advisors
Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications - Vimarsana News

Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications

Published: June 12, 2024

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell

Source: eagletribune.com
Related Topics:
France GeneralNew YorkUnited StatesNorth CarolinaJulien ValtonPascalyne WilsonArthur StrilCellecti PulseagileAshleyr RobinsonPatricia Sosa NavarroCellectis The Company Euronext GrowthSecurities Exchange CommissionNature CommunicationsEuronext GrowthVice President Gene TherapyAdult HemoglobinSickle HemoglobinNasdaq Global MarketPrivate Securities Litigation Reform ActAnnual ReportSosa NavarroInterim Chief Financial OfficerLifesci Advisors